1. Home
  2. BJDX vs JAGX Comparison

BJDX vs JAGX Comparison

Compare BJDX & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • JAGX
  • Stock Information
  • Founded
  • BJDX 2015
  • JAGX 2013
  • Country
  • BJDX United States
  • JAGX United States
  • Employees
  • BJDX N/A
  • JAGX N/A
  • Industry
  • BJDX Medical Specialities
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BJDX Health Care
  • JAGX Health Care
  • Exchange
  • BJDX Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • BJDX 2.9M
  • JAGX 3.4M
  • IPO Year
  • BJDX 2021
  • JAGX N/A
  • Fundamental
  • Price
  • BJDX $1.56
  • JAGX $2.24
  • Analyst Decision
  • BJDX
  • JAGX Strong Buy
  • Analyst Count
  • BJDX 0
  • JAGX 1
  • Target Price
  • BJDX N/A
  • JAGX $60.00
  • AVG Volume (30 Days)
  • BJDX 38.7K
  • JAGX 99.7K
  • Earning Date
  • BJDX 08-13-2025
  • JAGX 08-12-2025
  • Dividend Yield
  • BJDX N/A
  • JAGX N/A
  • EPS Growth
  • BJDX N/A
  • JAGX N/A
  • EPS
  • BJDX N/A
  • JAGX N/A
  • Revenue
  • BJDX N/A
  • JAGX $11,552,000.00
  • Revenue This Year
  • BJDX N/A
  • JAGX $22.41
  • Revenue Next Year
  • BJDX $55.56
  • JAGX $30.00
  • P/E Ratio
  • BJDX N/A
  • JAGX N/A
  • Revenue Growth
  • BJDX N/A
  • JAGX 13.93
  • 52 Week Low
  • BJDX $1.46
  • JAGX $2.19
  • 52 Week High
  • BJDX $37.50
  • JAGX $35.25
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 43.11
  • JAGX 29.03
  • Support Level
  • BJDX $1.52
  • JAGX $2.32
  • Resistance Level
  • BJDX $1.63
  • JAGX $2.79
  • Average True Range (ATR)
  • BJDX 0.07
  • JAGX 0.14
  • MACD
  • BJDX 0.00
  • JAGX 0.08
  • Stochastic Oscillator
  • BJDX 19.05
  • JAGX 8.33

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: